Evidence map›Paper›PMID 35028751›Full record

ArticleEuropean radiology2022

Lung vessel volume evaluated with CALIPER software is an independent predictor of mortality in COVID-19 patients: a multicentric retrospective analysis.

Chiara Romei, Zeno Falaschi, Pietro S C Danna, Chiara Airoldi, Michele Tonerini, Erika Rocchi, Salvatore C Fanni, Claudio D'Amelio, Greta Barbieri, Giusy Tiseo and 6 more

Abstract read
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chiara Romei *Department of Diagnostic Imaging, 2nd Radiology Unit, Pisa University-Hospital, Via Paradisa 2, Pisa, Italy. chiara.romei@gmail.com.ORCID http://orcid.org/0000-0003-3023-8784
Zeno Falaschi *Department of Diagnosis and Treatment Services, Radiodiagnostics, Azienda Ospedaliero Universitaria Maggiore Della Carità, Novara, Italy.
Pietro S C DannaDepartment of Diagnosis and Treatment Services, Radiodiagnostics, Azienda Ospedaliero Universitaria Maggiore Della Carità, Novara, Italy.
Chiara AiroldiDepartment of Translational Medicine, University of Eastern Piemonte, Novara, Italy.
Michele ToneriniDepartment of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
Erika RocchiDepartment of Diagnostic Imaging, 2nd Radiology Unit, Pisa University-Hospital, Via Paradisa 2, Pisa, Italy.
Salvatore C FanniDepartment of Diagnostic Imaging, 2nd Radiology Unit, Pisa University-Hospital, Via Paradisa 2, Pisa, Italy.
Claudio D'AmelioDepartment of Diagnostic Imaging, 2nd Radiology Unit, Pisa University-Hospital, Via Paradisa 2, Pisa, Italy.
Greta BarbieriDepartment of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
Giusy TiseoDepartment of Clinical and Experimental Medicine, University of Pisa, Via Paradisa 2, Pisa, Italy.
Roberto ArioliDepartment of Diagnosis and Treatment Services, Radiodiagnostics, Azienda Ospedaliero Universitaria Maggiore Della Carità, Novara, Italy.
Alessio PaschèDepartment of Diagnosis and Treatment Services, Radiodiagnostics, Azienda Ospedaliero Universitaria Maggiore Della Carità, Novara, Italy.
Ronald A KarwoskiDepartment of Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Annalisa De LiperiDepartment of Diagnostic Imaging, 2nd Radiology Unit, Pisa University-Hospital, Via Paradisa 2, Pisa, Italy.
Brian J BartholmaiDivision of Radiology, Mayo Clinic, Rochester, MN, USA.
Alessandro CarrieroDepartment of Diagnosis and Treatment Services, Radiodiagnostics, Azienda Ospedaliero Universitaria Maggiore Della Carità, Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionComputer-Aided Lung Informatics for Pathology Evaluation and Ratings (CALIPER) software has already been widely used in the evaluation of interstitial lung diseases (ILD) but has not yet been tested in patients affected by COVID-19. Our aim was to use it to describe the relationship between Coronavirus Disease 2019 (COVID-19) outcome and the CALIPER-detected pulmonary vascular-related structures (VRS). MATERIALS AND

methodsWe performed a multicentric retrospective study enrolling 570 COVID-19 patients who performed a chest CT in emergency settings in two different institutions. Fifty-three age- and sex-matched healthy controls were also identified. Chest CTs were analyzed with CALIPER identifying the percentage of VRS over the total lung parenchyma. Patients were followed for up to 72 days recording mortality and required intensity of care.

resultsThere was a statistically significant difference in VRS between COVID-19-positive patients and controls (median (iqr) 4.05 (3.74) and 1.57 (0.40) respectively, p = 0.0001). VRS showed an increasing trend with the severity of care, p < 0.0001. The univariate Cox regression model showed that VRS increase is a risk factor for mortality (HR 1.17, p < 0.0001). The multivariate analysis demonstrated that VRS is an independent explanatory factor of mortality along with age (HR 1.13, p < 0.0001).

conclusionOur study suggests that VRS increases with the required intensity of care, and it is an independent explanatory factor for mortality. KEY POINTS: • The percentage of vascular-related structure volume (VRS) in the lung is significatively increased in COVID-19 patients. • VRS showed an increasing trend with the required intensity of care, test for trend p< 0.0001. • Univariate and multivariate Cox models showed that VRS is a significant and independent explanatory factor of mortality.

Indexed as

COVID-19HumansInformaticsLungRetrospective StudiesSoftwareCALIPERComputed tomographyCOVID-19Sars-Cov2Texture analysis

Identifiers

PMID35028751
PMCPMC8757923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.